trending Market Intelligence /marketintelligence/en/news-insights/trending/vUh0Cc0HKQzSD6bt95ybjw2 content esgSubNav
In This List

Actinium Pharmaceuticals appoints analytical development director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Actinium Pharmaceuticals appoints analytical development director

Actinium Pharmaceuticals Inc. appointed Jeannine Larrieux director of analytical development.

Larrieux will oversee analytical assay development, biologics license applications and investigational new drug-enabling studies.

Larrieux previously worked as the head of analytical science and technology at Novartis.